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Looking back over the changes and developments of 2014, I would like to thank the 
staff of CDC’s Division of Tuberculosis Elimination (DTBE) and our partners in public 
health for everyone’s collective efforts in closing out the year with satisfaction and pride. 
We have weathered a number of significant changes this past year or two. As you 
recall, it was a year ago, on December 31, 2013, that Dr. Ken Castro announced his 
decision to vacate the position of Director of DTBE. Dr. Castro was the Director of 
DTBE for 20 years, and his departure was unanticipated. Fortunately, a number of our 
well-qualified staff have been serving in acting capacities, allowing the Division to 
remain very productive. A round-up of the Division’s accomplishments and major 
activities of the year include the following: 
 
When colleagues in state and local TB control programs struggled with shortages of 
drugs and diagnostics, DTBE staff developed and published reports in CDC’s Health 
Alert Network (HAN) and in the MMWR that provided guidance and interim 
recommendations. DTBE staff members continue to be involved in this challenging 
issue, because drugs and diagnostics remain vulnerable to supply interruptions. 
 
On March 18, CDC's Public Health Grand Rounds focused on multidrug-resistant 
(MDR) TB. This session included presentations by Sarita Shah of DTBE’s International 
Research and Programs Branch (IRPB) and Tom Shinnick, Associate Director for 
Global Laboratory Activities, in addition to two speakers from outside DTBE. Dr. Dalene 
van Delft, a survivor of MDR TB, was there to share her experiences. Also, the March 
21 edition of the MMWR included its annual article on preliminary U.S. TB surveillance 
data for 2013. Later in October, the final surveillance report for 2013 indicated a total of 
9,582 incident TB cases, reflecting our continued success in combatting TB. 
 
In May, CDC held its annual honor awards ceremony. The Antibiotic Resistance Threat 
Report team, a group that included several DTBE staff, won the Excellence in 
Communication award. Kudos to the recipients of that award! 
 
In August, DTBE welcomed three new EIS officers. Godwin Mindra joined the 
Surveillance, Epidemiology, and Outbreak Investigations Branch, and the International 
Research and Programs Branch welcomed Hannah Kirking and Colleen Scott. 
 
We have also had several retirements this year. Long-time DTBE senior staff who left 
CDC included Jose Becerra, Chief of  the Data Management and Statistics Branch 
(DMSB); Lorna Bozeman, Data Management Team Lead in the Clinical Research 
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Branch (CRB); Ken Castro, former Director, DTBE; Beverley DeVoe-Payton, Deputy 
Chief of CRB; and Bonnie Plikaytis, Acting Chief of the Laboratory Branch (LB).  
 
In December we also say farewell to two long-time DTBE staff who have contributed a 
great deal to DTBE and worked in collaboration with many of you. Cheryl Tryon and 
Ann Lanner of DTBE’s Communications, Education, and Behavioral Studies Branch are 
both retiring at the end of this year. Cheryl, a Health Education Specialist, has worked 
on several award-winning projects and has helped make many of DTBEs educational 
products and training courses expertly organized and formatted so as to maximize user 
access and understanding. Ann, a Public Health Analyst, has served in a variety of 
editorial and communications projects, including serving as Managing Editor of TB 
Notes since 1995. Owing to her retirement, the next issue of TB Notes will be delayed 
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Director 
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HIGHLIGHTS FROM STATE AND 
LOCAL PROGRAMS 
 
2014–2015 NTCA Board 
 
Guided by passion for what they do and a 
responsibility to the people they serve, with a 
commitment to their staff and colleagues in TB 
programs across the U.S., and holding the 
shared vision for a world free of TB, the members 
of the all-volunteer Board of the National TB 
Controllers Association (NTCA) donate their time 
guiding the organization. Over the last several 
years, as the organization has evolved, these 
voluntary positions are increasingly expanding in 
scope, time involvement, and potential for 
impact.  
 
The leadership of NTCA changes each June, at 
the conclusion of the National TB Conference. As 
the President steps down, the new President 
steps up, along with four newly elected 
incidence-level representatives (three for specific 
incidence levels and one at-large), a President-
elect, and a second member of the Executive 
Committee—either the Treasurer or the 
Secretary—on alternating years. This year, with 
the adoption of a new set of bylaws, the 
Presidents of the three sections, the National 
Society of TB Clinicians (NSTC), the National TB 
Nurse Coalition (NTNC), and the Society for 
Epidemiology in TB Control (SETC) are also 
assuming their places among the NTCA 
leadership as voting members of the Board.    
 
For 2014–2015, John Bernardo (MA) serves as 
the NTCA Board President, and Jenny Flood 
(CA) moves to the Immediate Past President 
position. Jane Moore (VA) continues for a second 
year serving in the Secretary position. Newly 
elected to the NTCA Executive Committee are 
Robert Belknap (CO-Denver) as the President-
Elect and Julie Higashi (CA-San Francisco) as 
the Treasurer.   
 
Newly elected incidence-level representatives:  
Nancy Baruch (MD) — high incidence 
Peter Davidson (MI) — medium incidence 
Kristin Rounds (SD) — low incidence 
Diana Fortune (NM) — at large 
 
These newly elected incidence-level 
representatives join colleagues who include 
Diana Nilsen (NY-NYC) — high incidence 
Rose Marie Sales (GA) — high incidence 
Heidi Behm (OR) — medium incidence  
Naveen Patil (AR) — medium incidence 
Denise Ingman (MT) — low incidence 
Lorna Will (WI) — low incidence 
 
Finally, the three newly elected Presidents of the 
NTCA sections are as follows: 
Barbara Seaworth (TX-Heartland TB Center) — 
National Society of TB Clinicians (NSTC) 
Barbarah Martinez (TX-Houston) — National TB 
Nurse Coalition (NTNC) 
Shama Ahuja (New York-NYC) — Society for 
Epidemiology in TB Control (SETC) 
 
These elected Board members meet by 
telephone conference every month, and each 
one participates in various committees and 
workgroups or serves as liaison to the federal TB 
initiatives, providing that much-needed field 
perspective. This volunteer commitment, on top 
of their regular “day jobs,” is intense, but they 
continue to give of their time and talent. We are a 
stronger organization for their leadership and 
they serve as role models for others. 
 
Please reach out to the Board and let them know 
how best they (and the organization they serve) 
TB 
Notes 
Centers for Disease Control and Prevention 
Atlanta, Georgia  30333 
Division of Tuberculosis Elimination ♦ 
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 
NUMBER 4, 2014 
5 
 
can represent you, your program, and those you 
serve. In addition, the NTCA has an expanding  
list of sections, committees, and workgroups. We 
can find a way for you to be involved, lending 
your expertise, experience, and passion for TB 
control (and elimination!) to achieve our goals, 
and ultimately, to benefit our abilities to continue 
protecting the public’s health from tuberculosis.  
 
To learn about opportunities for greater 
engagement in the work of the NTCA, please 
visit our website, www.tbcontrollers.org!  
 
—Submitted by Jennifer Kanouse 
and Donna Hope Wegener 
National TB Controllers Association 
 




The National Tuberculosis Controllers 
Association (NTCA) is a professional member 
organization that brings together the leaders of 
TB programs from across the country. Most 
often, surveys or inquiries about TB control 
programs go through NTCA. However, requests 
occasionally go directly to the TB controllers and 
program staff. Over the last several years, the 
number of survey requests has increased. These 
requests have come from various entities, 
including industry, government, other TB 
programs, partner organizations, and masters 
and doctoral students. These types of requests 
require significant time from the TB programs, 
and sometimes important requests might be 
overlooked, given other time constraints and 
competing priorities.   
 
Under Dr. Jon Warkentin’s leadership, the 2012–
2013 NTCA Board recognized the need for a 
central mechanism—a “clearinghouse” of sorts—
for these requests to be reviewed, enhanced, 
facilitated, and prioritized in order to minimize 
response burden. This happened concurrently 
with a newly recognized need to develop an 
NTCA research agenda. The Research and 
Survey Committee (RSC) was established in 
response to these needs in 2012. Sarah 
Burkholder agreed to serve as the inaugural 
Chair of the committee.  
 
Requests for time-sensitive surveys of TB control 
programs regarding issues of improvement of 
programmatic practices and outcomes started 
pouring in soon after the establishment of the 
Committee. Under Sarah’s leadership, a formal 
submission and review process was developed, 
which includes collaboration with the requestors 
to maximize the relevance of the data for the TB 
programs. The submission process is outlined 
below. 
 
In October 2013, Michelle Macaraig became 
Chair of the Committee and worked to formalize 
the roles of the RSC. During this time, NTCA was 
establishing a new section devoted to the 
epidemiology of TB. This section recognizes the 
critical role epidemiology plays and the 
increasingly important role that data and 
evidence-based decisions will have in the future 
TB Notes is a quarterly publication of the Division 
of TB Elimination (DTBE) of the National Center 
for HIV/AIDS, Viral Hepatitis, STD, and TB 
Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC). This material is in 
the public domain, and duplication is encouraged. 
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of TB control and elimination activities. The 
membership of this section brings substantial 
expertise and experience conducting, analyzing, 
and utilizing research.   
 
Recognizing both that the RSC had spent a 
majority of the time quickly responding to urgent 
data requests, and that the expertise and 
opportunities to find and conduct systematic 
research within TB programs existed in the 
epidemiology section, the committee decided to 
transfer all research responsibilities to the 
Epidemiology section. The RSC now focuses on 
the urgent survey requests that have immediate 
impact on TB programs, and was renamed the 
Survey Committee. Effective August 2014, the 
NTCA Survey Committee has oversight function 
and review of surveys involving TB controllers 
and TB program staff. 
 
Formal role for the committee 
The Survey Committee was established by the 
NTCA to organize and facilitate requests to 
survey TB control programs. The members of the 
committee consist of volunteers from TB control 
programs across the country with programmatic, 
clinical, and research experience.   
 
The role of the committee is to ensure the 
requests are consistent with the mission of NTCA 
and benefit the TB control programs. The 
members of the committee and the requestors 
work collaboratively to ensure that the data 
collected will be of interest to the programs, and 
develop (or refine) the survey. In some cases the 
surveys are administered by the requesting 
entity; in other instances, the NTCA staffers 
assume responsibility for creating an electronic 
survey instrument and administering it 
electronically. Collection, analysis, and 
ownership of the data are determined during the 
review process. 
 
Projects completed to date 
Even before the Committee was formed, NTCA 
was organizing its own data collections. Since its 
inception, the Committee has initiated or 
facilitated nine surveys designed to measure the 
capacity of TB programs to accomplish their 
mission in the context of declining resources and 
funding; to obtain information about TB drugs 
and diagnostics shortages experienced by the TB 
programs and community partners; use of, and 
demand for, rifapentine by TB control programs; 
and educational assessments of knowledge 
needed to successfully fulfill responsibilities 
within a TB control program.   
 
These projects have had direct impact on and 
are of direct benefit to our programs. In part, the 
survey work accomplished by this Committee—in 
partnership with both the Treatment Action Group 
and with Sanofi—resulted in a price drop for 
rifapentine.  
 
Who can make a request, and what is the 
submission process? 
Anyone can submit a request to the Survey 
Committee. Historically requests have come from 
NTCA, TB controllers and staff from TB control 
programs, CDC, academic institutions, and 
pharmaceutical companies.  
 
The process requires the submission of a 
standardized request form outlining the purpose, 
timeline, methods and anticipated benefits of the 
survey for TB control.  In addition, it requires the 
submission of a draft survey instrument and a 
copy of the investigator’s curriculum vitae.   
 
Process   
Complete the Survey Request Form and send to 
ntca@tbcontrollers.org or contact Dr. Michelle 
Macaraig, Chair, at mmacarai@health.nyc.gov. 
 
What types of information can be requested? 
Requests for information should be for the 
purposes of improving TB programmatic 
practices and outcomes. Survey topics can range 
from but are not limited to current TB control 
practices, interest in participating in new 
initiatives, or obtaining information about 
emerging challenges, issues, and conditions 
related to the TB control. 




NTCA Survey Committee members 
Michelle Macaraig, Chair, NY-NYC Dept of 
Health and Mental Hygiene  
Sheanne Allen, WA Dept of Health  
John Bernardo, MA Dept of Public Health/Boston 
University  
Marcos Burgos, NM Dept of Health/University of 
New Mexico  
Sarah Burkholder, IN State Dept of Health  
Jason Cummins, TN Dept of Health 
Peter Davidson, MI Dept of Community Health  
Karen Farrell, FL Dept of Health  
Jennifer Flood, CA Dept of Public Health  
Stephen Hughes, NY State Dept of Health  
Amanda Kita-Yarbro, Public Health Madison & 
Dane County, WI  
Mark Lobato, CDC, Division of Tuberculosis 
Elimination  
Diana Nilsen, NYC Dept of Health and Mental 
Hygiene  
Andrew Tibbs, MA Dept of Public Health  
Shu-Hua Wang, OH Dept of Health/The Ohio 
State University  
Jon Warkentin, TN Dept of Health  
Donna Wegener, NTCA  
Lorna Will, WI 
 
If you are interested in becoming part of the 
NTCA Survey Committee, please send an e-mail 
to ntca@tbcontrollers.org with your request to be 
included in monthly conference calls.  
 
—Submitted by Michelle Macaraig, DrPH, MPH 
Chair, NTCA Survey Committee 
NYC Dept. of Health and Mental Hygiene, 
Tuberculosis Control 
and Jennifer Kanouse and Donna Hope Wegener 
National Tuberculosis Controllers Association 
2014 Watsonian Society 
Banquet 
 
On Oct. 22, 2014, the Watsonian Society met for 
its annual banquet at the Marriott Century Hotel 
in Atlanta. The keynote speaker at the event was 
Rear Admiral (Retired) Kenneth G. Castro, 
former Director of the Division of Tuberculosis 
Elimination (DTBE). Dr. Castro also received the 
Honorary Public Health Advisor (PHA) Award 
from the Watsonian Society, a CDC employee 
organization representing the contribution of 
PHAs to the nation’s and the world’s public 
health. 
 
Each year, the membership of the Watsonian 
Society nominates and selects a candidate who 
has made one or more major contributions to the 
overall growth of the PHA series. In nominating 
Dr. Castro for the Honorary PHA Award, the 
Watsonian Society cited the following to justify 
his selection: “Under Dr. Castro’s leadership, 
DTBE established and maintained one of the 
agency’s largest groups of PHA field assignees, 
and he continually recognized and promoted the 
work of PHAs assigned to state/local health 
departments. He is an enthusiastic and 
consistent advocate for having PHAs in 
management roles, in recent years adding PHA 
deputy branch chief positions in DTBE branches. 
Dr. Castro is also a strong supporter of CDC 
programs such as the Public Health 
Apprenticeship Program (PHAP), which is 
designed to reestablish the PHA pipeline, 
providing financial and management support to 
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the program and hiring recent PHAP graduates 
for TB field assignments. Those who know Dr. 
Castro are quite familiar with his focus on the 
mission of disease prevention and control, and 
his disdain for bureaucratic hurdles and red tape. 
He came to rely strongly on PHAs because they 
can contribute to accomplishing the mission both 
directly through their programmatic work, as well 
as indirectly by navigating through and handling 
complicated administrative processes so the 
programmatic work could get done.” Dr. Castro 
certainly epitomizes the spirit of Public Health 
Advisors. 
 
In his keynote address, Dr. Castro acknowledged 
the contributions of PHAs in his early days at 
CDC. “In 1993, I was selected by Dr. Alan 
Hinman to become the Director of CDC’s Division 
of Tuberculosis Elimination, where I worked 
closely with several others listed here. Carl 
[Schieffelbein], Paul [Poppe], and Phil [Talboy] 
served as Deputy Directors, while Kate [O’Toole], 
Heather [Duncan], and Kathryn [Koski] served as 
Associate Directors for Management and 
Operations. I learned from all of them. In fact, as 
a young, brash Division Director at CDC, I stayed 
out of prison thanks to the guidance provided by 
Carl and Paul. As an innate problem-solver, God 
knows that I was prone to come up with solutions 
that were downright illegal, according to federal 
government rules. By the time Phil arrived as our 
Deputy, I had learned quite a bit from his 
predecessors.”  Dr. Castro also commented that, 
“Over the years, the attributes that have 
characterized PHAs have included the ‘can-do’ 
and ‘mission-oriented’ attitude, as well as 
mobility, resulting from being transferred multiple 
times, especially in the early parts of their 
careers. This allows PHAs to contribute a 
breadth of experience to local and state health 
departments.” 
 
He addressed challenges and opportunities for 
PHAs. As communication strategies have 
changed, he challenged PHAs to adopt new 
skills, particularly in the use of social media. He 
also spoke of the challenges of being frequently 
deployed to assist in disease outbreak 
investigations around the world. In addition, he 
described how we need to respond to the 
implementation of the Affordable Care Act. 
Analytical skills are critical for planning health 
promotion and disease control strategies. We 
need to ensure that the PHAs entering the public 
health system are prepared to deal with these 
new challenges. He concluded, “…If we are to be 
data-driven and data-informed, the Public Health 
Associate training program must develop, 
implement, and measure success and failures to 
revise and adapt our approach.” He emphasized 
the value of the servant leader: “A servant-leader 
focuses primarily on the growth and well-being of 
people and the communities to which they 
belong.”   
  
The Watsonian Society was formed to foster and 
continue professional and social relationships 
among PHAs. The Society was named for 
William C. Watson, who retired from CDC in 1984 
as CDC’s Deputy Director, the first and only 
person without a doctorate to reach that rank. 
Watson was recruited by the US Public Health 
Service to be an adviser in its venereal disease 
campaign, a program that was later shifted to 
CDC. Bill Watson made such a positive 
impression in his 36-year career with CDC that 
two of its hallmarks bear his name. One is the 
William C. Watson Jr. Medal of Excellence, which 
is CDC’s highest honor. The other is the 
Watsonian Society, which aims to inculcate the 
leadership attributes Watson embodied in future 
CDC managers. William Clarence Watson Jr., 
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died on December 23, 2013. He leaves a rich 
legacy to which we are the heirs.” 
 
If you would like more information about the 
Watsonian Society, please visit its website: 
http://www.cdc.gov/watsonian/. 
 
—Reported by Bob Kohmescher 
CDC Public Health Advisor 
Retired December 2011 
 
TB EDUCATION AND TRAINING 
NETWORK UPDATES 
 
2014 TB ETN Conference 
 
The TB Education and Training Network (TB 
ETN) held its 13th conference September 16–18, 
2014, in Atlanta, Georgia, in conjunction with the 
5th annual TB Program Evaluation Network (TB 
PEN) Conference. Over 200 participants 
attended from all over the world, representing 
state and local TB programs, nonprofit 
organizations, and academia. 
 
This year’s theme, “The Changing Landscape of 
TB,” inspired exciting presentations and activities 
throughout the 2½-day meeting. Dr. Jenny Flood 
provided the opening plenary speech, “The 
Changing Landscape of TB” (see details below, 
in the TB PEN summary). Plenary session topics 
included an overview of recent changes in TB 
control and prevention, an update on video DOT 
activities, including examples from state 
programs, and a panel discussion on contact 
investigations from a national and state 
perspective. Breakout sessions provided 
opportunities to delve further into topics, such as 
how to set up a video-observed therapy program, 
conduct effective presentations, promote World 
TB Day and other TB program activities, evaluate 
contact investigations, and evaluate the new 
LTBI drug regimen. In addition, the Regional 
Training and Medical Consultation Centers 
presented highlights of their activities and 
products and held meetings with states from their 
respective regions. A highlight of the conference 
was the ETN and PEN Focal Point Meetings.  
 
This conference marked the 5th year for the TB 
Educator of the Year Award and the Project 
Excellence Award. These awards were 
established in 2010 to recognize excellence in 
TB health education and training by TB ETN 
members around the world. Wanda Walton, PhD, 
Chief of CDC’s Communications, Education, and 
Behavioral Studies Branch, announced the 
winners and presented the awards. Following are 
Dr. Walton’s remarks. 
 
The TB Educator of the Year award recognizes 
an individual who has shown dedication and 
leadership in the field of TB education and 
training. There were many excellent 
nominations, and for the first time ever, we had 
a tie for this award! The two winners of this 
year’s award are Ann Jackson and Alexandra 
Santana Camacho. 
 
Ann Jackson is a Nurse Consultant with the 
Office of TB and Refugee Health at the 
Mississippi State Department of Health. Ann 
has been described as a ‘training dynamo’ who 
has worked more to increase the awareness of 
TB in Mississippi than any other individual. As 
an example of the training she provides, Ann 
conducts an average of 78 day-long classroom 
TB trainings per year and certifies about 2,500 
individuals, mostly nurses, per year (that’s over 
10,000 people in the last 4 years!). She also 
strives to make training more accessible and 
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affordable. Recently, she hosted a live online 
training on ‘TB interviewing basics,’ followed by 
in-person regional classroom sessions using 
role play and videotaping of practice interviews 
for feedback and improvement. She is also 
responsible for maintaining and updating the 
TB program manual. These are just a few of 
the many, many examples of the work Ann 
does regarding TB education and training.  
 
 
Alexandra Santana Camacho is the TB 
Program Educator at the Puerto Rico 
Department of Health. When Alexandra joined 
the Puerto Rico TB Control Program, there had 
been no consistent health educator for more 
than 5 years. Her first activities on the job were 
updating and standardizing the program’s 
employee orientation plan, updating the 
program’s website, and developing a 
comprehensive Spanish-language TB guide for 
physicians, nurses, and other health care 
providers. She also hosted a Spanish-language 
TB contact investigation (CI) course after 
translating hundreds of English-language slides 
into Spanish. Her 4-day CI course in June 2014 
was the first formal CI training to be offered to 
the more than 20 technicians and nurses of the 
Puerto Rico TB Program. In summary, 
Alexandra has worked to build a multifaceted, 
high quality, culturally appropriate TB 
education program in just over a year’s time.   
 
 
The Project Excellence award recognizes 
exceptional health education and training 
products or activities that have been developed 
by TB ETN members within the past 2 years. 
The 2014 TB Project Excellence Award goes to 
the ‘TB Sputum Collection Video.’  This project 
was developed by Madison and Dane County 
TB public health staff in Wisconsin. The team 
consisted of Julia Greenleaf, Nancy Odell, 
Jesse Ramirez, Kate Louther, Lorna Will, and 
Jeff Golden.  
 
The TB Sputum Collection Video was 
developed to address the lack of effective 
instructions or videos to help TB patients learn 
how to provide TB sputum specimens. The 
team applied for and received a grant for the 
video production from the Wisconsin Medical 
Society Foundation. The video was then 
produced by program staff and eventually 
translated into Spanish, Hmong, and Nepali. 
Since the development of the original English 
video, it has been translated into 15 additional 
languages, including Khmer, Swahili, Karen, 
Vietnamese, French, and Russian. All of the 
videos are available on the program’s website. 
 
Dr. Wanda Walton and Dr. Terry Chorba, Chief of 
DTBE’s Field Services and Evaluation Branch, 
closed out the meeting with updates from their 
respective branches. 
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Congratulations to the 2014 award winners! And 
thanks to all the individuals who worked tirelessly 
behind the scenes to make this another 
successful conference for training and evaluation 
staff throughout the country. 
 
—Reported by Peri Hopkins, MPH 
Health Education Specialist 
Div of TB Elimination 
 
TB PROGRAM EVALUATION 
NETWORK UPDATES 
 
5th TB Program Evaluation Network 
(TB PEN) Conference and Program 
Evaluation Focal Point Meeting 
 
The TB Program Evaluation Network held its 5th 
annual conference September 16–18, 2014, in 
conjunction with the TB Education and Training 
Network (ETN). A total of 38 Program Evaluation 
(PE) focal points from TB control programs 
across the country attended. These PE focal 
points have been assigned as part of DTBE 
efforts to develop and strengthen the capacity of 
state and local TB programs to monitor and 
evaluate their programs and to enhance the 
effectiveness and programmatic accountability of 
TB prevention and control activities. 
 
 
The keynote speaker, Dr. Jennifer Flood, Chief of 
the TB Control Branch, California Department of 
Public Health, focused on the key changes in TB 
prevention and control: the implication of the 
Affordable Care Act (ACA); cases becoming 
fewer but more complex; program evaluation 
progress; and the implications of education, 
evaluation, and training. Topics of joint plenary 
sessions with the ETN included video observed 
therapy, TB contact investigation (CI), and 
updates from DTBE on education and training, 
and program evaluation activities. Other 
conference activities included breakout sessions, 
workshops, skill building sessions, and a poster 
session. Topics of PE breakout sessions 
included Program Evaluation 101, a discussion of 
the new latent TB infection (LTBI) regimen, ACA: 
opportunities for partnerships, and contact 
investigation evaluation. 
 
The breakout session on contact investigations 
offered participants the chance to highlight the 
creative and innovative approaches they have 
undertaken to successfully evaluate CIs along 
with the opportunity to discuss database 
development and usage, peer counseling, 
policies, and recommendations for future CI 
activities. 
 
Cheryl Kearns, Chair of the TB PEN Steering 
Committee, facilitated an open forum discussion 
session among focal points, the TB PEN Steering 
Committee, and DTBE staff on how to improve 
communication among these stakeholders and 
discuss evaluation expectations for the coming 
year. Field Services and Evaluation Branch staff, 
DTBE leadership, and the Program Evaluation 
Team Lead also participated in the discussion. 
 
The final TB PEN session, developed in 
response to previous conference evaluations, 
focused on National Tuberculosis Indicator 
Project (NTIP) calculations. Detailed information 
regarding the completion of treatment within 12 
months and sputum culture conversion within 60 
days of treatment initiation indicators was 
presented, with additional time for questions 
about other indicators of interest. 
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The joint conference featured 25 posters, 18 of 
which represented TB program evaluation 
activities (Figure 1). Poster presentation topics 
included contact investigation; cohort review; 
cost of TB treatment and case management; 
data quality alerts and program performance; 
directly observed therapy; the 12-dose isoniazid-
rifapentine regimen for LTBI treatment, also 
known as 3HP; MDR TB; refugee and immigrant 
evaluation; TB outbreaks; TB treatment delays; 
and TB drug shortages. Two of the TB PEN 
posters were selected for oral presentation. The 
posters, titled “Using California’s Tuberculosis 
Program Assessment Tool (TPAT) to Track Local 
Infrastructure and Resource Changes” and “Cost 
of TB Treatment, Evaluation, and Case 
Management” were presented by Melissa Ehman 
and Kate Louther, respectively, during the local 
presentation plenary session.  
 
Preliminary comments indicate the TB PEN 
Conference was a great success. Formal 
evaluations are being reviewed and will be 
shared with the TB PEN Conference Planning 
Committee when they reconvene in the fall of 
2015. If you have further suggestions for the 
2016 TB PEN Conference or would like to 
participate on the planning committee, please 
send an email to tbpen@cdc.gov 
 
—Reported by Cheryl Kearns 
TB PEN 
 
TB TRIALS CONSORTIUM 
(TBTC) UPDATES 
 
CDC Tuberculosis Trials Consortium 
(TBTC) Study 33 (IAdhere) 
 
CDC’s Tuberculosis Trials Consortium (TBTC) 
Study 26 trial, Prevent TB, demonstrated the 
safety and effectiveness of the new 3-month, 12-
dose regimen for latent TB infection (LTBI). The 
trial studied isoniazid (H) and rifapentine (P) 
given once weekly by directly observed therapy 
(DOT) for 3 months (3HP) compared with 9 
months of daily, self-administered therapy (SAT) 
with INH alone (9H)(New Engl J Med 2011; 365: 
2155).  
 
Owing in part to cost and logistical constraints, 
SAT has been used most commonly with 
regimens for treatment of LTBI; DOT has been 
reserved for select individuals at increased risk of 
poor adherence, based on factors such as 
homelessness, incarceration, and drug or alcohol 
addiction. 
 
The 3HP regimen was developed largely 
because its requirement for only 12 doses, 
compared to a minimum of 240 doses for 9H, 
would make treatment of LTBI more feasible, 
thereby increasing acceptance and treatment 
completion rates in patients with LTBI. However,
Figure 1. Number of Abstracts Submitted for the TB PEN Conference, 2009–2012 and 2014 
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the programmatic costs of DOT have limited 
wider uptake of the new regimen. Cost studies 
have indicated that the new regimen may be cost 
effective from some perspectives even when 
used with DOT, but would be cost saving from all 
perspectives if SAT could be used and still 
achieve similar levels of adherence as DOT (Int J 
Tuberc Lung Dis 2014; 18:751). 
 
Recognizing the importance of costs in adopting 
3HP, in 2012, TBTC initiated Study 33, an 
international randomized trial to assess treatment 
completion of 3HP when given as SAT. Having 
this additional clinical trial also provides another 
opportunity to assess safety of the regimen and a 
first opportunity to evaluate whether safety might 
be affected by changing the mode of drug 
administration from DOT to SAT. 
 
Study 33, also called the IAdhere study, enrolled 
1,002 participants in the United States of 
America, Spain, Hong Kong, and the Republic of 
South Africa. All persons have now completed 
treatment and follow-up phases. The trial 
collected data on adherence using patient report, 
pill counts, scheduling information, and electronic 
bottle caps. Information on safety included data 
on discontinuations, as well as information on 
signs, symptoms and other events reported in 
study participants prior to and during the 
treatment. Preliminary results of the safety 
analysis were presented at the 45th UNION 
World Conference on Lung Health, as part of the 
UNION/CDC Late Breaker Session (Int J Tuberc 
Lung Dis 2014: 18 [11 Suppl 1]: S1 – S592). 
Data on the adherence outcomes of the study, 
comparing patients’ adherence to 3HP in two 
SAT groups and one DOT group, are currently 
being analyzed. Presentation of these results is 
expected early in 2015. 
 
—Reported by Andrey S. Borisov, MD, MPH, Study 
33 (IAdhere) Project Officer 
Div of TB Elimination 
 
Reasons LTBI Patients Declined or 
Enrolled in TBTC Study 33 
 
As noted above, TBTC Study 33 assessed 
adherence to the 3-month, 12-dose once-weekly 
regimen of isoniazid and rifapentine (3HP) when 
given by DOT (directly observed therapy), SAT 
(self-administered therapy), or SAT with weekly 
short messaging service reminders. 
 
To assess the generalizability of study results 
and to facilitate recruitment efforts in future trials, 
investigators recorded reasons why persons who 
were initially approached about the study were 
not enrolled. 
 
Persons not enrolled by their own choice were 
asked about reasons for declining. Additionally, a 
sample of study participants who did enroll were 
asked to report their motivations for enrolling. 
 
Almost half of the 2,171 persons screened for 
participation were not enrolled. The top reasons 
for study decline included concerns surrounding 
study medications and reluctance to undergo 
treatment or participate in research. Among 
those enrolling, frequent reasons included 
access to shorter treatment regimens and 
improving health.  An analysis of these data was 
presented as a poster at the 45th UNION World 
Conference on Lung Health in October; a 
subsequent publication is planned.  
 
—Reported by Kimberley Chapman, MPH, 
and Joan Mangan, PhD 







2014 TB Program Managers’ Course 
 
Overview of the TB Program Managers’ Course 
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The overall purpose of the TB Program 
Managers’ Course is to improve the planning and 
managerial capabilities of new TB program 
managers throughout the country. The course is 
designed for TB controllers, program managers, 
public health advisors, and nurse consultants 
with programmatic responsibilities at the state, 
big city, territory, or region (within a state) level. 
Optimally, a course participant should have 
occupied a TB program management position for 
at least 6 months, but no more than 3 years. 
Participants are nominated by the DTBE 
Program Consultant for their area. 
 
2014 TB Program Managers’ Course 
The DTBE Communications, Education, and 
Behavioral Studies Branch (CEBSB) would like to 
thank the faculty and participants of the 2014 TB 
Program Managers’ Course for making the 
course such a success. The hard work of the 
faculty in preparing the materials for their 
sessions and the participants’ efforts during the 
course are greatly appreciated. 
 
Based on the 2012 needs assessment feedback 
to decrease the out-of-office time required for 
attending the course, this year’s course was 
revised to consist of a web-based and an in-
person portion. The web-based portion consisted 
of a series of six webinars held in August and 
September 2014. The in-person portion of the 
course was held October 7–9, 2014, at the 
Courtyard Marriott in Decatur. The 3-day in-
person training was divided into 13 sessions. 
Each webinar or session stood alone as a block 
of instruction, but it was sequenced to build 
logically on the webinar/sessions preceding it. 
The course concluded with a charge to the 
participants from Dr. LoBue and an opportunity 
for each participant to share what he or she had 
learned. 
 
The course stressed the practical application of 
planning, management, and evaluation concepts 
to the specific needs and activities of TB 
programs. Skills essential to TB program 
management were presented, followed by 
exercises and polling questions that encouraged 
participants to use knowledge learned. Some 
new additions to the course were “Program 
Planning with Reduced Resources” and 
“Understanding Cooperative Agreements.” 
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For the participants, the course is not entirely 
over. They will be mailed a 6-month follow-up 
questionnaire in April 2015. Once this 
questionnaire is completed and returned, each 
participant will receive a certificate of completion 
for the course. 
 
—Reported by Allison Maiuri, MPH, CHES, 
Sarah Segerlind, MPH, and 
 Molly Dowling, MPH, CHES 
Div of TB Elimination 
 




TB Data Users Group 
 
The TB Information Systems Team of DTBE’s 
Data Management and Statistics Branch (DMSB) 
performs all software development activities 
within the DTBE; provides helpdesk support for 
those applications that are in production; 
supports the state TB programs with IT advice 
and some support for the TB surveillance 
systems; and monitors the National TB 
Surveillance data to verify, validate and ensure 
the quality and completeness of the case data 
submitted. 
 
In 2010, soon after U.S. public health 
jurisdictions began transitioning from the TIMS 
legacy system to the multiple National Electronic 
Disease Surveillance Systems (NEDSS), the 
DMSB TB Information Systems Team received a 
request from two surveillance coordinators for 
help in creating a forum to share information 
among all the TB data users. The coordinators 
wanted a forum in which their colleagues in state 
programs could address surveillance issues of 
similar concern (i.e., development of reports to 
extract useful data from NEDSS, especially data 
needed to address our cooperative agreement 
requirements). Since the data needs are similar 
among jurisdictions, this approach seemed to be 
the most practical, rather than having these 
issues raised in each jurisdiction, which would 
lead to multiple isolated solutions. In June 2010, 
the TB Information Systems Team stepped up to 
the plate and Stacey Parker became the primary 
logistics coordinator for the group to help them 
get organized. This group is now the TB Data 
Users Group (TDUG). Stacey provides the setup 
for a monthly conference call or webinar, as 
needed by the group, and is the hub for 
distribution of agendas and notes, as well as 
coordinating the support for CDC and subject 
matter expert (SME) presentations. 
 
TDUG members develop the agenda for topics of 
discussion, and the discussions are lively and 
informative. Now entering its fifth year, the group 
has held monthly calls discussing various topics 
related to surveillance data. Some of these topics 
have included RVCT, including drill downs on 
specific items, such as the Moved or the Risk 
Factor question, NTIP, including discussion of 
specific algorithms for calculating Completion of 
Therapy and Drug Susceptibility Testing, and 
NTSS reports and data gathering for expanding 
reports. State users have shared custom-
designed tools and reports that they use to assist 
with issues of data quality and even non-RVCT 
data tracking, such as contacts and LTBI. 
 
TDUG has become a highly effective forum for 
sharing information across multiple state TB 
programs, as well as improving CDC-provided 
applications and processes, such as the NTSS 
Reports and the Case Closeout Process. Many 
ideas for improvement have begun with 
discussions in this group. Stacey ensures that 
key SMEs are available for the call, as indicated 
by the current topic, and that the Information 
Systems Team Lead (Sandy Price) and a 
member of the RVCT Quality Team (either Elvin 
Magee or Lilia Manangan) is available for 
questions during any discussions. Those 
questions that cannot be answered during the 
call are pursued between calls and addressed 
during the next meeting or through email 
correspondence. 
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TDUG has a standing call on the third Tuesday of 
each month at 2:00 pm Eastern time. Generally, 
each call has a topic for discussion or 
demonstration, as well as time for questions and 
answers and discussion of other topics. Agendas 
are provided to the group 1 or 2 days in advance, 
and notes are always compiled and sent out after 
the call. Teresa Goins from the Kentucky 
Department of Health stated after receiving the 
meeting slides, “AWESOME!!!… I always print 
and make use of any slides and notes you 
send—they are valuable to me.” If you are not a 
member of this distinctive group and think that it 
might be helpful to you, please contact the TB 
Applications Helpdesk (email 
DTBESupport@cdc.gov or call 888-300-4261) 
and ask to be included. We would love to have 
you join the discussion. 
 
—Reported by Sandy Price 
Div of TB Elimination 
 
INTERNATIONAL RESEARCH 
AND PROGRAMS BRANCH 
UPDATES 
 
Handbook for Analysis of TB 
Surveillance Data 
 
This fall, the World Health Organization (WHO) 
published a handbook, Understanding and Using 
Tuberculosis Data, to increase the capacity of TB 
program staff to analyze TB surveillance data 
and make data-driven decisions to improve their 
programmatic response. Country health 
information systems collect rich data on their 
burden of TB, but for a variety of reasons, TB 
program staff members tend to underuse these 
data. This in turn affects their ability to monitor 
the epidemic and assess progress towards TB 
targets. The WHO handbook is designed to build 
analytic capacity and encourage data use by 
taking readers step-by-step through examples on 
how to analyze TB surveillance data and use the 
results to make decisions.   
 
The handbook is a product of the WHO Global 
Task Force on Impact Measurement.1 The 
development of Understanding and Using 
Tuberculosis Data was a collaborative effort 
between WHO, the Division of Tuberculosis 
Elimination at CDC, and other technical agencies 
(e.g., KNCV and Public Health England) during 
2012–2014. The handbook incorporates TB 
surveillance data from over 30 countries, with 
authors drawing heavily on their local and global 
experiences in working to assess, use, and 
improve TB surveillance data.  
 
The book’s eight chapters are 
1. Analysis of aggregated TB notification data 
2. Analysis of case-based TB notification data 
3. Using genotyping data for outbreak 
investigations 
4. Analysis of factors driving the TB epidemic 
5. Drug-resistant TB: analysis of burden and 
response 
6. HIV-associated TB: analysis of burden and 
response 
7. Estimating TB mortality using vital 
registration and mortality survey data 
8. Combining surveillance and survey data to 
estimate TB burden  
 
Readers can access Understanding and Using 




—Reported by Deanna Tollefson, MPH, 
and Emily Bloss, PhD, MPH, MA 
Div of TB Elimination 
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Historic Microscope on Display at 
David J. Sencer CDC Museum 
 
DTBE’s Laboratory Branch recently donated an 
original microscope used by Charles C. Shepard, 
MD, for display at CDC’s David J. Sencer 
Museum. Dr. Shepard, who was Chief of the 
Leprosy and Rickettsia Branch at CDC for more 
than 30 years, was an internationally recognized 
microbiologist who contributed immensely to the 
scientific knowledge and characterization of 
mycobacterial diseases. The donated 
microscope was used for work with 
Mycobacterium leprae. In 1960, Dr. Shepard was 
successful in growing M. leprae in laboratory 
animals, which had never been achieved before. 
This advance enabled scientists to test potential 
treatments and preventive measures for leprosy. 
 
Dr. Shepard is also known for his diligent efforts 
that contributed to the discovery of the causative 
agent of Legionnaires’ disease, Legionella 
pneumophila, in 1977. 1 After his death in 1986, 
CDC established the Charles C. Shepard Award. 
The award honors the memory of Dr. Shepard, 
whose career was marked by the pursuit of 
scientific excellence. This prestigious award is 
presented each year to recognize scientific 
achievement by CDC and ATSDR authors of the 
most outstanding peer-reviewed research paper 
published during the preceding year.2 Access 





This photograph shows Dr. Shepard carrying out 
microscopic examinations of slides in his 
laboratory, ca. 1960. Photo courtesy of the CDC 
Public Health Image Library. 
 
—Submitted by Frances Tyrrell, MPH, 
and David Temporado, BS, 
Div of TB Elimination 
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Leeanna Allen, MPH, MCHES, joined CEBSB as 
a Health Communication Specialist on October 
20, 2014. Leeanna started her career at CDC in 
2008 in CDC’s National Center for Environmental 
Health, Radiation Studies Branch, where she 
worked on radiological and nuclear terrorism 
preparedness communication and training 
initiatives. She previously served as training and 
exercise coordinator in the hospital preparedness 
program in the Georgia Division of Public Health, 
and also as an emergency risk communicator 
and health educator for the Arizona Department 
of Health Services.  
 
Leeanna received her BS from the Georgia 
Institute of Technology, and her MPH from 
Emory University. She is looking forward to new 
challenges and opportunities in DTBE. 
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Yesmel Bodden-Santos, MA, has joined the 
DTBE/SEOIB Surveillance Team as the Branch's 
first CDC evaluation fellow, supported and 
provided by CDC’s Program Performance and 
Evaluation Office. In collaboration with FSEB's 
Program Evaluation Team, Yesmel will help 
conduct surveillance cost estimates, TB 
surveillance training evaluation, and analysis for 
quality improvement processes. 
 
Yesmel has an MA degree in Community 
Psychology with a concentration in program 
development from the University of New Haven, 
CT. Yesmel’s interest in public service was 
fueled by her mother’s work as an epidemiologist 
in the Dominican Republic. Yesmel’s long travels 
with her mother to forgotten and marginalized 
communities living in extreme poverty fostered 
her passion to seek effective and innovative 
ways to make a difference. 
 
Lorna Bozeman retired on September 30, 2014, 
after 31 years of service at CDC. Lorna was 
Team Leader of the Data Management Team in 
DTBE’s Clinical Research Branch. For the past 
18 years, Lorna has been the lynchpin in the TB 
Trials Consortium (TBTC) Data and Coordinating 
Center, serving both as Data Management Team 
Leader and as Microbiology Liaison. She is 
possibly the most recognized of all TBTC staff, 
interacting with virtually everyone at every TBTC 
site. She has been deeply respected for her 
commitment, her technical excellence, her 
teamwork, her cheerfulness, and her strong 
sense of fairness. She will be much missed. 
 
Lorna grew up on a farm in Needham, 
Massachusetts, the first born of fraternal twin 
sisters, and one of four sisters, all with names 
starting with an “L.” She attended Needham High 
School, and then headed south to attend college; 
during this time, she met and married Earl 
Bozeman. She graduated in 1975 from the 
University of South Carolina with a BS in Biology. 
She worked in a veterinary clinic over the next 
several years to support her continued education; 
in 1982 she earned a master’s degree in Medical 
Microbiology from the University of Georgia. She 
enrolled in a program in clinical microbiology at 
Emory Hospital and achieved Board certification. 
 
In 1984 she came to CDC, and briefly worked in 
John Brooks’ lab on tuberculostearic acid as a 
diagnostic agent for TB meningitis. She then 
worked for 6 years in the HIV laboratory of Dr. 
Steve McDougal, during the time that this 
laboratory identified the CD4 molecule as the 
primary receptor for HIV, and GP120 as the 
primary viral binding protein. In 1990, she left the 
laboratory to work for 6 years as an 
epidemiologist with the Agency for Toxic 
Substances and Disease Registry, investigating 
toxic waste accumulations at federal facilities.  
 
In 1996 she interviewed for a position in DTBE's 
Clinical Research Branch, to serve as 
microbiology liaison and epidemiologist with the 
group involved in USPHS Study 22 (the 
rifapentine trial). She remained with this group for 
the next 18 years. Over time, she assumed 
increasing responsibility for TBTC data 
management; in 2004 she became Data 
Management Team Leader, directing the data 
management operations for all TBTC studies. 
She supervised a highly capable staff, with whom 
she assured the security and quality of trial data. 
She trained a succession of students from 
Emory’s Rollins School of Public Health, assuring 
the continuation of experienced and skilled data 
management staff for TBTC. She was a co-
author on most of TBTC’s major trial reports, 
including Studies 22, 24, 27, 29, and the most 
recent report on the 12-dose regimen for LTBI, 
also known as 3HP (Study 26).  
 
Lorna provided a superb example to others. She 
came early and often left late. She was, however, 
dedicated to living a full life. Her two daughters 
Eva and Arrie were often present, and she 
shared their experiences with many of her 
colleagues and friends. Her contributions were 
constant and innumerable, and her smiling 
presence, strong sense of equity, and dedication 
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to quality data in service of important public 
health goals will be greatly missed. 
 
Danielle Burt, a first-year graduate student at 
Emory University Rollins School of Public Health, 
joined CEBSB in October. Danielle graduated 
from Furman University in May 2014, earning a 
BS degree in Health Sciences. She became 
interested in TB prevention and education during 
a study abroad trip to South Africa, Namibia, and 
Botswana, where she visited hospitals, clinics, 
and NGOs dealing with TB issues. 
 
For the past 3 years, Danielle has served as a 
Research Assistant and Assistant Coordinator for 
LiveWell Greenville, an organization in 
Greenville, SC, that works to make 
environmental improvements in schools, 
workplaces, churches, health care settings, and 
recreational facilities to “make the healthy choice 
the easy choice.” Danielle conducted research on 
how the labeling of healthier options affected 
food purchases at Greenville County water parks 
during the summers of 2012–2014, and she 
presented the findings at two professional 
conferences. In addition, she assisted with the 
completion of a multimillion-dollar CDC-funded 
grant application, wrote newsletters, and created 
various toolkits. Danielle has enjoyed her time at 
CDC so far and is excited about continuing to 
learn from her colleagues. 
 
Deron Burton, MD, joined DTBE's Clinical 
Research Branch on October 1. Deron comes to 
CRB having most recently served as Acting 
Deputy Branch Chief and the Lead for Pediatric 
TB and TB/HIV for IRPB here in DTBE. Prior to 
joining IRPB, Deron served as a Medical 
Epidemiologist and as the Deputy Director for 
Science for CDC’s International Emerging 
Infections Program, Division of Global Health 
Protection, Center for Global Health, in Kisumu 
and Nairobi, Kenya. He led the development of, 
and served as the Principal Investigator for, a 
new surveillance project for meningitis and 
encephalitis in Kenya, and he mentored a team 
of six Kenyan public health scientists conducting 
infectious disease monitoring and intervention 
studies in western Kenya.  
 
Deron joined CDC in 2004 as an Epidemic 
Intelligence Service Officer with the Respiratory 
Diseases Branch in NCIRD. He was a preventive 
medicine resident in New York City, and then 
worked during 2007–2009 in CDC’s Division of 
Healthcare Quality Promotion (DHQP), where he 
led an investigation of serious bloodstream 
infections among patients in intensive care in the 
U.S. In 2009, he was recruited for a detail as part 
of the Transition Team for the new CDC Director; 
his skill in providing rigorous scientific and policy 
analyses resulted in his selection as Special 
Advisor for Infectious Diseases to the Director of 
CDC (2010). CDR Burton also served as the 
Associate Director for Health Equity in the 
National Center for Health Marketing (2008–
2009), where he served as part of the senior 
Center leadership team and led a Center-wide 
council that developed strategies to improve the 
Center’s impact in the area of health equity 
promotion. 
 
Deron is board certified in Preventive Medicine. 
In addition, he clerked for the DC Circuit of the 
U.S. Court of Appeals, and holds degrees in 
English, law, medicine, public health, and 
aerospace engineering! 
 
Beth Gardner has joined IRPB on a 120-day 
detail to serve as the Deputy Branch Chief.  Beth 
comes to us from the National Center for 
Environmental Health (NCEH) and the Agency 
for Toxic Substances and Disease Registry 
(ATSDR). For the past 7 years she has held the 
Extramural Team Leader position, reviewing and 
approving all contracts, grants and COAGs, and 
Interagency Agreements (IAAs) for the Center. 
Previously she was the Technical Information 
Management Section (TIMS) Team Leader in 
PGO Policy and implemented the electronic 
application process to CDC through Grants.gov. 
Her first position at CDC was in the National 
Immunization Program with the Extramural 
Research Office as an ORISE fellow. 
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Stephanie Johnston, MS, joined the Laboratory 
Branch on November 30, 2014, as the Team 
Lead of the Laboratory Capacity Team. 
Stephanie received her BS degree from 
Jacksonville University and her MS degree from 
Georgia Southern University. She began her 
career at CDC in 1998 as a Microbiologist in the 
National Center for Infectious Diseases, Division 
of Parasitic Diseases, where she led the 
development of the highly regarded DPDx 
website, which allows for telediagnosis of 
parasites of public health concern submitted by 
partners throughout the world. In 2009, 
Stephanie transitioned to the Laboratory Training 
Branch, which is currently part of the Center for 
Surveillance, Epidemiology, and Laboratory 
Services, and had served as Team Lead 
supervising course designers in this branch 
starting in 2012. During her time in the 
Laboratory Training Branch, she worked closely 
with CDC subject matter experts and various 
public health agencies to ensure continued 
scientific development of public health 
laboratorians in areas such as public health 
policy, practice, and testing methods. 
 
Awal Khan, PhD, of FSEB has been appointed 
the DTBE Health Equity Coordinator. Over the 
last several years, the DTBE Health Equity 
Workgroup has been addressing this critical area 
as it relates to TB elimination. This dedicated 
group of DTBE staff has been led by Awal Khan 
as chair and Elvin Magee and Gail Burns-Grant 
as co-chairs, with additional workgroup members 
Suzanne Marks, Allison Maiuri, Deanna 
Tollefson, Dolly Katz, Frances Tyrell, and Joan 
Mangan. Recently, Justin Davis has joined the 
workgroup to represent DTBE OD. To ensure this 
crucial work is adequately recognized and 
supported by DTBE, Dr. Phil LoBue appointed a 
Health Equity Coordinator for DTBE. He asked 
Awal Khan to take on this role, in addition to his 
program evaluation responsibilities, because of 
his exceptional leadership and dedication in this 
area. The duties of this position include serving 
as the primary point of contact for Health Equity 
activities for DTBE and regularly updating DTBE 
OD and DTBE senior staff on these activities. 
Congratulations to Awal and the rest of the 
workgroup for taking on this important mission. 
 
Ann Lanner is retiring at the end of 2014 after 36 
years of service with the federal government, 
most of it with CDC. She has been with the 
NCHHSTP Division of Tuberculosis Elimination 
since 1993, first as a writer-editor and later as a 
Public Health Analyst. 
 
Ann grew up in a military family. They lived in 
Turkey and Germany and visited many 
interesting places, eventually settling in Atlanta. 
Ann attended high school here; she was on the 
staff of the school newspaper, and worked in her 
local library during summers and after school. 
Graduating in 1971, she attended Furman and 
Clemson universities in South Carolina, and 
graduated cum laude with a degree in English in 
1975. Between 1975 and 1985 she held four 
different jobs in three different cities. In January 
1985 she came to CDC and knew she had found 
her “home.” 
 
Ann’s first position at CDC was in the then-
named Personnel Management Office, where 
she learned all about CDC’s great work and 
people. During this time she married her husband 
David, and in September 1989, David Jr. was 
born. 
 
She returned to work in December 1989 and took 
a position in the Division of HIV/AIDS Prevention. 
At that time, Dr. Jim Curran was Director; Drs. 
Ken Castro, Peter Drotman, Harold Jaffe, and 
John Ward were also there in various deputy 
positions. She also worked in the Center for 
Prevention Services’ HIV Prevention Office, 
where she worked with Dr. Ron Valdiserri, Gary 
West, Steve Schindler, and other smart, talented 
people. 
 
In April 1993, Ann transferred to the Division of 
Tuberculosis Elimination (DTBE). In 1995, she 
took over as managing editor of TB Notes 
newsletter and has produced it since that time. In 
NUMBER 4, 2014 
23 
 
addition to TB Notes, Ann worked on a variety of 
projects involving writing, editing, publishing, and 
analysis. She worked for a number of years on 
the Center’s annual report, and contributed to 
various CDC newsletters, fact sheets, budget-
related justifications, reports, and other 
documents. She was involved for many years 
with the CDC task order for the development of 
the TB Weekly News Update, and for a while, 
between contractors, she produced it herself. 
She was responsible for compiling DTBE journal 
article citations, and also researched and 
provided advice on copyright issues. She 
enjoyed working and talking to others at CDC 
during the years she helped with the Combined 
Federal Campaign. She also enjoyed working 
with colleague Nicole Richardson-Smith and 
others at CDC and in state and local health 
departments in developing the TB Personal 
Stories project. This involved interviewing former 
TB patients and posting their stories on the 
DTBE website as a way to promote the essential 
work of U.S. TB control programs. 
 
In 2005, she received the NCHHSTP 
Communications Services honor award. In 2012, 
the DTBE policy team, on which she served, 
received an NCHHSTP Honor Award in the 
Excellence in Finance category. Her colleagues 
generously included her in other awards as well. 
But the main prize has been working here, with 
great supervisors and coworkers and interesting 
work, which made it a pleasure to come to work. 
 
Along the way, she has been fortunate to know 
and learn from inspiring and generous editors 
and communicators such as John Anderton, 
Elliott Churchill, Marie Morgan, Karen Resha, 
and others. She learned the ins and outs of 
copyright law from Sue Carlson. She greatly 
enjoyed working with Kathy Nellis Chastney and 
the CDC Connects staff on numerous features. 
 
Being part of creative projects with colleagues 
will be one of her fondest memories. Two such 
projects served as bookends to her career: In 
1994, DTBE sponsored a contest to name a new 
electronic tool for tracking annual health care 
worker testing; Ann’s entry, staffTRAK-TB, was 
selected and she won a fabulous chocolate cake 
as the prize. More recently, she wrote several 
articles about Scarlet Crow’Hara and Edgar Allan 
Crow, the scarecrows / TB education products 
that her Branch coworkers created for the 
Scarecrows in the Garden contest at the Atlanta 
Botanical Garden—sweetened by winning First 
Place in the nonprofessional category in 2013, 
the year they created E.A. Crow. 
 
In retirement, after losing the alarm clock, Ann 
plans to read, travel, volunteer, ponder long-
ignored home and garden projects, and 
reconnect with the long-lost art of relaxation. 
 
Scott Lee joined DTBE’s Data Management and 
Statistics Branch on September 30, 2014, as an 
ORISE fellow. He is currently here working part-
time while completing his PhD at the University of 
Georgia, where he has studied and taught for the 
past 5 years; he will begin full-time work in 
January 2015. During his time as a fellow, Scott 
will work under DMSB Acting Branch Chief Chad 
Heilig to learn more about the practice of public 
health statistics and to prepare himself for what 
he hopes to be a long and rewarding career of 
service at CDC. Among other things, he is 
interested in applying the advanced probability 
models he implemented for his dissertation 
research to answer questions relating to the 
spread and control of TB. Having studied 
English, music, and linguistics in addition to 
epidemiology and biostatistics, Scott has a 
diverse academic background that he also hopes 
will enable him to make valuable contributions to 
the ongoing and future research projects in the 
branch. 
 
Allison Maiuri, MPH, has left DTBE to accept a 
position as a health communication specialist 
with the National Center for Immunization and 
Respiratory Diseases (NCIRD)’s Division of Viral 
Diseases (DVD).  Her last day in the office was 
November 14, 2014. 
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Allison has been a valued member of DTBE’s 
Communications, Education, and Behavioral 
Studies Branch (CEBSB) for the past 8 years on 
the Education, Training, and Behavioral Studies 
Team. Allison first came to DTBE in 2006 as an 
Association of Schools of Public Health (ASPH) 
fellow. During her time at DTBE, she was 
responsible for managing, marketing, monitoring, 
and evaluating the Find TB Resources.cdc.gov 
website. This role included redesigning the site 
based on feedback from user testing. She also 
worked on the recently revised Self-Study 
Modules, 6–9, using input from subject matter 
experts as well as TB guidelines. Allison was 
very involved in training activities conducted by 
CEBSB.  She planned, organized, and evaluated 
the TB Program Managers’ Course, as well as 
the annual Training and Education Focal Points 
meeting.  In addition, for several years, she 
served as the co-chair for the IUATLD Education 
and Training Workgroup. She will be missed, and 
we wish her well! 
 
Tiffany Neal has joined CRB on detail as Deputy 
Branch Chief. Tiffany comes to us from the 
National Center on Birth Defects and 
Developmental Disability, Division of Human 
Development and Disability, Childhood 
Development and Disability Branch. For the past 
7 years, she has been the Lead Public Health 
Advisor/Program Manager for the Rare Disorders 
and Health Outcomes Team. In this capacity, she 
worked with 31 research grantees implementing 
the Branch’s registries and surveillance activities, 
and provided technical assistance and 
consultation in budget formulation and execution, 
personnel management, policy and 
communication, and program management, in 
support of the muscular dystrophy, spina bifida, 
and fragile X programs. 
 
Chuck Nsiegbe, PhD, has been assigned to 
DTBE as our new OCFO Budget Analyst.  He 
was previously with the Division of Adolescent 
and School Health (DASH) and replaces Patsye 
Ervin, who departed a few months ago. 
 
Chuck has a vast amount of federal experience 
in accounting, finance, and systems. He is a 
proud US Army Veteran. Chuck earned his 
doctorate in IT Project Management from Capella 
University this year. Chuck also holds an MBA in 
Accounting and an MS degree in Information 
Communication Science.  
 
Chuck’s accomplishments include being an 
integral member of the Enterprise Resource 
Planning (ERP) financial systems replacement 
initiative for CDC, which launched CDC’s UFMS. 
Chuck’s knowledge spans systems analysis and 
design as well as financial systems integration, 
all of which enables him to provide exceptional 
budget analysis and presentation.  
 
Robbie Payne joined the Office of the Director, 
Resource Management Team, on Nov. 17 as our 
new Budget Lead. He will be working closely with 
the OCFO Budget Analyst, OD, and the DTBE 
branches to strengthen budget tracking and 
analysis in the Division. 
 
Robbie comes to us from the National Center for 
Chronic Disease Prevention and Health 
Promotion, where he most recently served as a 
project officer in the Arthritis Program. Robbie 
has worked in the field of arthritis the past 9 
years of his 18-year career in public health. 
Before joining the Arthritis Program, Robbie 
managed a CDC Division budget that 
encompassed 12 Congressionally mandated 
programs totaling over a quarter-billion dollars 
annually. Prior to this, Robbie served as liaison 
between end users and programmers on a Team 
that designed an internal CDC management 
information system that is still in use across the 
agency today. 
 
Erin Sizemore has returned to CRB/DTBE, after 
working 2 years as an epidemiologist in the 
Program Evaluation Branch, Division of 
HIV/AIDS Prevention, Intervention Research and 
Support. Erin is serving on the Data Management 
Team, where she supports a wide variety of 
functions previously led by Lorna Bozeman.  




Erin first came to CRB in 2004 as a work-study 
student through the Emory/Rollins School of 
Public Health. She used her work here to provide 
the basis for her MPH thesis. After graduation, 
she left briefly to work at Grady Hospital as an 
Infection Control Associate, but returned in 2006 
to work as an epidemiologist and data manager 
supporting TBTC Study 26. She eventually 
managed quality assurance for active TBTC 
studies, served as project officer on multiple sub-
studies, and was a representative to the 
Implementation and Quality Committee, and the 
Pharmacokinetic and other work groups. She 
was a member of the Study 26 team that won the 
Shepard Award in 2012. Erin left in 2012 for a 
promotion in DHAP, where she managed large 
datasets and conducted national-level quality 
assurance in support of HIV program evaluation. 
She returned on detail in May 2014 and was 
offered a permanent position in December. 
 
Jacek Skarbinski, MD, joined IRPB on August 23, 
2014, as the DTBE medical officer to be 
stationed in New Delhi, India. He will be working 
with the Ministry of Health and partners to 
improve TB control in India. He will be stationed 
in India in early 2015. 
 
Jacek started his CDC career in 2009 as an 
Epidemic Intelligence Service Officer in the 
Malaria Branch of the Division of Parasitic 
Diseases and Malaria. From 2009 to 2011, he 
worked on implementation of the President’s 
Malaria Initiative (PMI) in Malawi, as well as 
numerous research studies in Tanzania, Ghana, 
Malawi, and Kenya. His research activities 
included clinical trials of new antimalarials, 
observational studies on prevention of malaria in 
pregnant women, household surveys to assess 
the prevalence of malaria disease and 
intervention coverage, studies of novel 
diagnostics and diagnostic algorithms, and 
research to develop strategies to improve malaria 
case management.  
 
Most recently, from 2011 to 2014, he served as 
the Team Leader of the Clinical Outcomes Team 
in the Division of HIV/AIDS Prevention (DHAP), 
which administers the Medical Monitoring Project 
(MMP), a nationally representative surveillance 
system designed to assess clinical and 
behavioral characteristics of adults infected with 
HIV receiving care in the United States. In this 
position, he led a diverse team of medical 
officers, epidemiologists, sociologists, behavioral 
scientists, and statisticians to collect and 
disseminate data on strategies for improving HIV 
prevention and treatment in the United States.  
 
Jacek received his medical degree from Stanford 
University School of Medicine, completed his 
clinical training in internal medicine at the 
University of California-San Francisco, and 
completed an Infectious Diseases Fellowship at 
the Emory University School of Medicine. He has 
authored or co-authored more than 50 scholarly 
articles and has received awards for his scientific 
and public health contributions, including two 
nominations for the Charles C. Shepard Science 
Award and two NCHHSTP Director’s Recognition 
Awards.  
 
Phil Talboy returned to DTBE on September 30. 
For the past year, he has been on sequential 
details, first as a Senior Public Health Advisor to 
the CDC Public Health Apprentice Program, and 
then as Deputy Director of the CDC Global 
Disease Detection Center in China. Phil will be 
serving as a Senior Public Health Advisor in 
DTBE OD working on cross-cutting issues, 
including staff development. Welcome back to 
DTBE, Phil! 
 
Cheryl Tryon, MS, is retiring after a 40-year 
career, 27 years of which were with CDC. While 
she has had many job titles, her work always 
focused on instructional design: designing, 
developing, evaluating, and implementing health 
education materials and courses. In 1987, she 
began her first job at CDC in the Division of 
Media and Training Services; in 2002 she started 
working in the Global AIDS Program; and in 2006 
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she joined the Division of Tuberculosis 
Elimination, in the Communications, Education, 
and Behavioral Studies Branch. Prior to coming 
to CDC, she worked for 13 years at several 
Texas medical schools developing health 
education materials. In one of these positions, 
she also supervised a section of medical 
illustrators, graphic artists, and medical 
photographers. Cheryl received her MS degree in 
Biomedical Communications from the University 
of Texas Health Science Center at Houston and 
a BA degree in Art/Art Education from the 
University of South Florida, Tampa. 
 
Cheryl thanks her lucky stars every day for her 
wonderful career at CDC and never dreamed she 
would work on so many fascinating and important 
projects. In addition, she had the opportunity to 
collaborate with talented, knowledgeable, and 
noteworthy colleagues from whom she learned 
so much along the way. It meant a lot to Cheryl 
to be able to use her skills to help people live 
longer, healthier lives, and she has felt honored 
to work with the people who are at the forefront 
of the fight against TB and HIV in the United 
States and in developing countries. She hopes 
her efforts have helped them develop knowledge 
and skills that can ease their burden in 
confronting these two devastating diseases.  
 
Cheryl had numerous memorable projects, one 
of which was working on a slide presentation for 
Dr. C. Everett Koop for one of the early AIDS 
conferences. She produced a number of 
videotapes that teach people how to prevent 
infectious diseases such as Hantavirus, botulism, 
and mother-to-child-transmission of HIV. She 
helped develop many tuberculosis training 
projects such as the Self-Study Modules on 
Tuberculosis, the Mantoux Tuberculin Skin Test 
videotape, and the Report of Verified Case of 
Tuberculosis Self-Study Modules. During the 
1990s she helped create several important CDC 
exhibits for the annual American Public Health 
Association (APHA) conferences. The topics of 
these exhibits included CDC’s 50th Anniversary; 
Preventionville (a village that highlighted the 
impact of public health); and Ten Great Public 
Health Achievements, 1900–1999.  
One project she’s most proud of has been the 
award-winning Teachback Methodology 
curriculum and trainings she has provided with 
Peri Hopkins and other CDC colleagues. This 
unique training-of-trainers method allows 
attendees to not only learn course content, but to 
also learn training skills and then teach content to 
fellow students. Since 2003, it has been used 
with 42 TB and HIV courses to enhance training 
capacity and build a competent training 
workforce. Cheryl has provided these trainings in 
18 countries throughout North America, Africa, 
Asia, Europe, and the Caribbean, resulting in the 
training of 901 participants from over 80 
countries.  
 
She feels proud and fortunate that projects she 
has worked on have won over 20 international, 
national, and CDC awards for excellence in 
media design and health education. These 
included awards for training courses, videotapes, 
web sites, satellite uplinks, print materials, and 
exhibits. She shares credit for these awards with 
the wonderful clients who had meaningful 
projects and with talented and dedicated project 
team members who had very high production 
standards. 
 
Cheryl loves her job, but she is looking forward to 
retirement so she can spend more time with 
friends and family, especially her step-daughter 
and granddaughter. She also plans on traveling 
to faraway places like Africa, Machu Picchu, and 
the Galapagos Islands. She will pursue her many 
interests and hobbies and will continue to create 
oil paintings, grow hundreds (maybe even 
thousands) of flowers in her garden, ride her 
bicycle through area parks, and kayak on nearby 
lakes (avoiding white-water and rocks of course). 
She will miss working with her special colleagues 
and friends at CDC, especially those in DTBE. 
She will miss them all dearly. 
 





Katie Smith, a business services support 
specialist with NCHHSTP’s Administrative 
Services Unit (ASU), passed away on October 
26, 2014, after a brief illness. She worked for the 
CDC family for 21 years. Katie was first 
employed with NCHHSTP’s Division of 
Tuberculosis Elimination in the International 
Branch, and later joined the ASU.  Prior to joining 
CDC, Katie worked for Fulton County 
Government. 
Katie was very active in her church and was a 
member of the choir and the Vessels of Purpose 
ministry. She also enjoyed reading, cooking, and 
going to the movies.  She will be remembered for 
her kindheartedness and willingness to serve 
others.  She was also very outgoing and enjoyed 
inspirational conversations with old and new 
acquaintances. 
 
Katie was a native of Atlanta, GA.  She is 
survived by her daughter, Breon Smith; her 
sister, Marie Burney; two nieces, Cheree 
Hawkins and Nicole Burney; and one nephew, 
Virgil Burney, Jr.  She was a remarkable person 
and will be greatly missed by her family, friends, 
and colleagues.  
 
Services were held on November 1, 2014, at the 
Sword of the Lord Ministries in East Point, GA. 
 
Rita Varga, former Public Health Advisor with 
DTBE’s Field Services and Evaluation Branch, 
died on December 3, 2014. Rita had retired from 
CDC on February 27, 2009, with 23 years of 
service to CDC. 
 
Rita began her Civil Service career in February 
1986 as a co-op in CDC’s Sexually Transmitted 
Disease program starting in Indianapolis, IN. 
Following assignments in Fulton County, GA, 
Boston, MA, Chicago, IL, and Los Angeles, CA, 
Rita transferred to DTBE in 1994 with an 
assignment as the Training Coordinator in New 
York City. Rita continued to work with the NYC 
PHA cohort until they were well on their way to 
successful careers. 
 
In 1999, Rita transferred to Atlanta as the 
Training Coordinator for the DTBE Field Services 
Branch. In addition to those responsibilities, she 
worked as the headquarters member for the Field 
Staff Work Group. The group is dedicated to 
helping field staff workers remain up to date 
about what is happening at the CDC “mother 
ship.” 
 
Rita was an active member of the Field Staff 
Planning Work Group, a center-wide advisory 
group that coordinates field staff concerns with 
other CDC entities. Among her other 
associations, Rita was a long-time member of the 
TB Notes team as well as the former DTBE 
awards committee.  An active member of the 
Watsonian Society, Rita was that group’s 
newsletter editor starting in 2002. 
 
Prior to her federal service, Rita was a dedicated 
science teacher for 14 years in New Jersey, 
where she taught biology, chemistry, earth 
science, and physics to high school students. 
Although she enjoyed teaching, she wanted to 
expand her horizons and see the world, or at 
least the United States, and did so with CDC. 
 
After retirement, Rita remained in the Atlanta 
area. She loved gardening, crafting, and 
shopping. She always thought of others and was 
generous in spirit and in action. She had a can-
do attitude about everything that crossed her 
path. Rita knew how to laugh and see the lighter 
side even in dark situations. Her perseverance in 
seeing things through to completion will be 
greatly missed. Rita loved her career with CDC, 
and she in turn was highly regarded by those 
who knew her and worked with her.  
 
A memorial service will be held December 21, 
2014, in Lawrenceville, Georgia. 
§ 
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CALENDAR OF EVENTS 
 
January 22–27, 2015 
Host Response in TB (J3)  





February 23–26, 2015 
Conference on Retroviruses and Opportunistic 
Infections (CROI) 
Seattle, WA 




February 26–28, 2015 






April 15–18, 2015 
Denver TB Course 
Denver, CO 
National Jewish Health 
http://www.nationaljewish.org/tbcourse 
 
April 20, 2015 





April 20–24, 2014 




April 22, 2015 




May 15–20, 2015 





May 18–21, 2015 
APHL Annual Meeting and 9th Government 





June 9–11, 2015 
2015 National TB Conference: “Managing TB in a 
Global Society” 
Pre-meetings June 8, 2015; Post-meetings June 
11 and 12, 2015 
Grand Hyatt Atlanta in Buckhead 
Atlanta, GA 
 
August 24–26, 2015 
International Conference on Emerging Infectious 




September 14–17, 2015 
Program Managers’ Course 
Atlanta, GA 
Contact: Molly Dowling (mdowling@cdc.gov)   
 
September 26–29, 2015 
American College of Epidemiology Annual 
Meeting 
Atlanta, GA 
American College of Epidemiology 
http://www.acepidemiology.org/content/save-
date-ace-2015-annual-meeting 
 
 
